Episode 122: NCI Director Shares Research and Innovation During COVID-19

Norman “Ned” Sharpless, MD, director of the National Cancer Institute (NCI), joins Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss NCI’s COVID-19 coronavirus research efforts, how the agency is partnering with oncology nurses to understand the best care for patients with COVID-19 and cancer, nursing innovation during the pandemic, and the implications of delayed screening and care on future cancer incidence rates.   

Music Credit: "Fireflies and Stardust" by Kevin MacLeod  

Licensed under Creative Commons by Attribution 3.0 

Episode Notes  

Check out these resources related to today’s episode:   

• The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities. 
• Oncology Nursing Podcast Episode 106: NINR Director Discusses Nursing Research Amid COVID-19  
• ONS Voice article: Federal Agencies Collaborate; Nurse Proposes Healthcare Bill; NCI Shifts Research to COVID-19  
• ONS Voice article: NCI Cancer Research Persists Despite COVID-19 Limitations   
• ONS Recommendations for Oncology Staff Assignments During the COVID-19 Pandemic  
• ONS Interim Guidelines During the COVID-19 Pandemic  
• Dr. Sharpless’s Science Editorial on COVID-19 and Cancer 
• Childhood Cancer Data Initiative (CCDI) 
• The NCI Bottom Line Blog 
• NCI Community Oncology Research Program (NCORP) 
• NCI COVID-19 in Cancer Patients Study  
• NCI’s COVID-19 Information for Cancer Researchers  
• NCI-MATCH Trial